Six of the seven participants reported “an improvement in symptoms” and “none of the participants reported any adverse side effects.”
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
“The findings of this study indicate that neither past nor current cannabis use are associated with the likelihood of having clinical hypertension,” investigators concluded.
One-in-four respondents reported reducing their need for medical interventions since using cannabis, and nearly one-third acknowledged reducing their use of prescription medications.
“[T]he impacts of recreational cannabis legalization on psychiatric and psychosocial outcomes are otherwise minimal,” researchers concluded.
The use of cannabis products was associated with “statistically significant improvements in IBD-specific outcomes” at three months.
Compared to those residing in legal states, residents in states were marijuana was illegal “reported a significantly greater number of days driving under the influence of cannabis.”
Investigators concluded, “All patient-reported outcomes showed a statistically significant improvement at 3 months, which was maintained or further improved over the remainder of the 12-month follow-up.”
“[The] patient’s behavior rapidly improved” following THC treatment and he was eventually discharged from in-patient treatment to home care.